We recognise that any increase in hospital proactive deprescribing due to the CHARMER approach will have an impact on primary care, after the person is discharged. To understand the effects of CHARMER on primary care, we will be inviting colleagues whose patient(s) have had a medicine stopped to take part in an interview (either by telephone or online, e.g., Teams).

For more information, see the Participant Information Sheet.

We have established a Primary Care Advisory Group. The group meets twice yearly at key time points in the CHARMER project. The purpose of the group is to make sure that hospital proactive deprescribing is effectively communicated to primary care.

CHARMER PCAG Terms of Reference

For further information about the Primary Care Advisory Group, contact the CHARMER team at charmer.study@leicester.ac.uk.